annual EBITDA:
$156.68M+$140.38M(+861.21%)Summary
- As of today (August 29, 2025), NUTX annual EBITDA is $156.68 million, with the most recent change of +$140.38 million (+861.21%) on December 31, 2024.
- During the last 3 years, NUTX annual EBITDA has fallen by -$24.90 million (-13.71%).
- NUTX annual EBITDA is now -13.71% below its all-time high of $181.58 million, reached on December 31, 2021.
Performance
NUTX EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
$77.30M-$42.18M(-35.30%)Summary
- As of today (August 29, 2025), NUTX quarterly EBITDA is $77.30 million, with the most recent change of -$42.18 million (-35.30%) on March 31, 2025.
- Over the past year, NUTX quarterly EBITDA has increased by +$71.67 million (+1271.61%).
- NUTX quarterly EBITDA is now -35.30% below its all-time high of $119.48 million, reached on December 31, 2024.
Performance
NUTX quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
$228.34M+$71.67M(+45.74%)Summary
- As of today (August 29, 2025), NUTX TTM EBITDA is $228.34 million, with the most recent change of +$71.67 million (+45.74%) on March 31, 2025.
- Over the past year, NUTX TTM EBITDA has increased by +$206.16 million (+929.61%).
- NUTX TTM EBITDA is now at all-time high.
Performance
NUTX TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
NUTX EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +861.2% | +1271.6% | +929.6% |
| 3 y3 years | -13.7% | +143.9% | +73.3% |
| 5 y5 years | +3611.9% | +9756.6% | +3664.0% |
NUTX EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -13.7% | +1718.2% | -35.3% | +394.9% | at high | +1011.3% |
| 5 y | 5-year | -13.7% | +3611.9% | -35.3% | +394.9% | at high | +1011.3% |
| alltime | all time | -13.7% | +3611.9% | -35.3% | +394.9% | at high | +1011.3% |
NUTX EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $77.30M(-35.3%) | $228.34M(+45.7%) |
| Dec 2024 | $156.68M(+861.2%) | $119.48M(+693.3%) | $156.68M(+240.9%) |
| Sep 2024 | - | $15.06M(-8.7%) | $45.96M(+31.8%) |
| Jun 2024 | - | $16.50M(+192.8%) | $34.87M(+57.2%) |
| Mar 2024 | - | $5.64M(-35.7%) | $22.18M(+35.7%) |
| Dec 2023 | $16.30M(+89.2%) | $8.76M(+120.7%) | $16.35M(+218.9%) |
| Sep 2023 | - | $3.97M(+4.0%) | $5.13M(-120.5%) |
| Jun 2023 | - | $3.81M(-2071.2%) | -$25.06M(+10.6%) |
| Mar 2023 | - | -$193.50K(-92.1%) | -$22.66M(-345.6%) |
| Dec 2022 | $8.62M(-95.3%) | -$2.46M(-90.6%) | $9.23M(+66.7%) |
| Sep 2022 | - | -$26.22M(-522.2%) | $5.53M(-94.9%) |
| Jun 2022 | - | $6.21M(-80.4%) | $108.16M(-17.9%) |
| Mar 2022 | - | $31.69M(-615.0%) | $131.77M(+37.3%) |
| Dec 2021 | $181.58M(-5628.0%) | -$6.15M(-108.1%) | $96.00M(-5.8%) |
| Sep 2021 | - | $76.41M(+156.2%) | $101.88M(+310.0%) |
| Jun 2021 | - | $29.83M(-830.2%) | $24.85M(-478.3%) |
| Mar 2021 | - | -$4.08M(+1415.7%) | -$6.57M(+100.0%) |
| Dec 2020 | -$3.28M(-26.4%) | -$269.50K(-56.8%) | -$3.28M(-46.4%) |
| Sep 2020 | - | -$623.70K(-60.8%) | -$6.13M(-4.4%) |
| Jun 2020 | - | -$1.59M(+98.7%) | -$6.41M(+2.4%) |
| Mar 2020 | - | -$800.50K(-74.3%) | -$6.25M(-1.5%) |
| Dec 2019 | -$4.46M(+431.2%) | - | - |
| Dec 2019 | - | -$3.11M(+243.6%) | -$6.35M(+75.0%) |
| Sep 2019 | - | -$905.20K(-37.1%) | -$3.63M(+24.4%) |
| Jun 2019 | - | -$1.44M(+60.1%) | -$2.92M(+62.6%) |
| Mar 2019 | - | -$898.50K(+131.5%) | -$1.79M(+58.3%) |
| Dec 2018 | -$839.90K(-53.8%) | -$388.20K(+101.6%) | -$1.13M(+52.1%) |
| Sep 2018 | - | -$192.60K(-38.8%) | -$744.80K(-20.6%) |
| Jun 2018 | - | -$314.60K(+32.4%) | -$938.30K(-39.3%) |
| Mar 2018 | - | -$237.60K(-38.5%) | -$1.55M(+6.0%) |
| Dec 2017 | -$1.82M | - | - |
| Sep 2017 | - | -$386.10K(-58.2%) | -$1.46M(+27.0%) |
| Jun 2017 | - | -$922.70K(+514.3%) | -$1.15M(+295.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2017 | - | -$150.20K(+98.7%) | -$290.30K(-40.3%) |
| Dec 2016 | -$448.10K(-15.8%) | - | - |
| Sep 2016 | - | -$75.60K(+17.2%) | -$485.90K(-8.7%) |
| Jun 2016 | - | -$64.50K(-60.1%) | -$532.00K(+3.4%) |
| Mar 2016 | - | -$161.80K(-12.1%) | -$514.70K(+4.0%) |
| Dec 2015 | -$532.30K(-31.4%) | -$184.00K(+51.2%) | -$494.80K(-13.1%) |
| Sep 2015 | - | -$121.70K(+157.8%) | -$569.40K(-9.7%) |
| Jun 2015 | - | -$47.20K(-66.7%) | -$630.90K(-19.5%) |
| Mar 2015 | - | -$141.90K(-45.1%) | -$783.80K(+1.0%) |
| Dec 2014 | -$775.60K(+7.6%) | -$258.60K(+41.2%) | -$775.70K(+50.0%) |
| Sep 2014 | - | -$183.20K(-8.4%) | -$517.10K(+5.4%) |
| Jun 2014 | - | -$200.10K(+49.6%) | -$490.50K(+7.8%) |
| Mar 2014 | - | -$133.80K(-14.6%) | -$454.90K(-65.0%) |
| Dec 2013 | -$720.70K(-50.4%) | - | - |
| Sep 2013 | - | -$156.60K(-4.8%) | -$1.30M(-2.0%) |
| Jun 2013 | - | -$164.50K(-18.2%) | -$1.32M(-4.3%) |
| Mar 2013 | - | -$201.10K(-74.1%) | -$1.39M(-4.7%) |
| Dec 2012 | -$1.45M(+73.3%) | -$776.50K(+324.8%) | -$1.45M(+58.8%) |
| Sep 2012 | - | -$182.80K(-18.6%) | -$915.10K(-5.7%) |
| Jun 2012 | - | -$224.60K(-16.7%) | -$970.10K(+3.4%) |
| Mar 2012 | - | -$269.50K(+13.1%) | -$938.10K(+11.9%) |
| Dec 2011 | -$838.70K(-37.6%) | -$238.20K(+0.2%) | -$838.60K(-19.4%) |
| Sep 2011 | - | -$237.80K(+23.5%) | -$1.04M(-6.9%) |
| Jun 2011 | - | -$192.60K(+13.3%) | -$1.12M(-7.2%) |
| Mar 2011 | - | -$170.00K(-61.4%) | -$1.20M(-10.4%) |
| Dec 2010 | -$1.34M(+96.8%) | -$440.30K(+39.7%) | -$1.34M(+4.2%) |
| Sep 2010 | - | -$315.20K(+12.9%) | -$1.29M(+13.9%) |
| Jun 2010 | - | -$279.20K(-9.9%) | -$1.13M(+19.3%) |
| Mar 2010 | - | -$310.00K(-19.8%) | -$949.90K(+39.2%) |
| Dec 2009 | -$683.40K(+248.3%) | -$386.60K(+145.8%) | -$682.40K(+130.7%) |
| Sep 2009 | - | -$157.30K(+63.9%) | -$295.80K(+113.6%) |
| Jun 2009 | - | -$96.00K(+125.9%) | -$138.50K(+225.9%) |
| Mar 2009 | - | -$42.50K | -$42.50K |
| Dec 2008 | -$196.20K | - | - |
FAQ
- What is Nutex Health Inc. annual EBITDA?
- What is the all time high annual EBITDA for Nutex Health Inc.?
- What is Nutex Health Inc. annual EBITDA year-on-year change?
- What is Nutex Health Inc. quarterly EBITDA?
- What is the all time high quarterly EBITDA for Nutex Health Inc.?
- What is Nutex Health Inc. quarterly EBITDA year-on-year change?
- What is Nutex Health Inc. TTM EBITDA?
- What is the all time high TTM EBITDA for Nutex Health Inc.?
- What is Nutex Health Inc. TTM EBITDA year-on-year change?
What is Nutex Health Inc. annual EBITDA?
The current annual EBITDA of NUTX is $156.68M
What is the all time high annual EBITDA for Nutex Health Inc.?
Nutex Health Inc. all-time high annual EBITDA is $181.58M
What is Nutex Health Inc. annual EBITDA year-on-year change?
Over the past year, NUTX annual EBITDA has changed by +$140.38M (+861.21%)
What is Nutex Health Inc. quarterly EBITDA?
The current quarterly EBITDA of NUTX is $77.30M
What is the all time high quarterly EBITDA for Nutex Health Inc.?
Nutex Health Inc. all-time high quarterly EBITDA is $119.48M
What is Nutex Health Inc. quarterly EBITDA year-on-year change?
Over the past year, NUTX quarterly EBITDA has changed by +$71.67M (+1271.61%)
What is Nutex Health Inc. TTM EBITDA?
The current TTM EBITDA of NUTX is $228.34M
What is the all time high TTM EBITDA for Nutex Health Inc.?
Nutex Health Inc. all-time high TTM EBITDA is $228.34M
What is Nutex Health Inc. TTM EBITDA year-on-year change?
Over the past year, NUTX TTM EBITDA has changed by +$206.16M (+929.61%)